Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
37.64
-0.74 (-1.93%)
At close: Dec 10, 2025, 4:00 PM EST
37.75
+0.11 (0.29%)
After-hours: Dec 10, 2025, 6:16 PM EST

Vericel Revenue

Vericel had revenue of $67.50M in the quarter ending September 30, 2025, with 16.58% growth. This brings the company's revenue in the last twelve months to $258.72M, up 14.05% year-over-year. In the year 2024, Vericel had annual revenue of $237.22M with 20.10% growth.

Revenue (ttm)
$258.72M
Revenue Growth
+14.05%
P/S Ratio
7.28
Revenue / Employee
$724,697
Employees
357
Market Cap
1.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024237.22M39.71M20.10%
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020124.18M6.33M5.37%
Dec 31, 2019117.85M26.99M29.71%
Dec 31, 201890.86M26.93M42.13%
Dec 31, 201763.92M9.54M17.54%
Dec 31, 201654.38M3.22M6.28%
Dec 31, 201551.17M22.37M77.69%
Dec 31, 201428.80M28.78M151,457.89%
Dec 31, 201319.00K-2.00K-9.52%
Dec 31, 201221.00K3.00K16.67%
Dec 31, 201118.00K-71.00K-79.78%
Jun 30, 201089.00K-93.00K-51.10%
Jun 30, 2009182.00K-340.00K-65.13%
Jun 30, 2008522.00K-163.00K-23.80%
Jun 30, 2007685.00K-178.00K-20.63%
Jun 30, 2006863.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings